Nippon Chemiphar is a Japanese pharmaceutical company primarily engaged in the manufacture and sale of prescription (ethical) pharmaceuticals, with additional operations in healthcare, beauty, and real estate leasing. The company is also advancing its own drug discovery pipeline, including a Phase IIa clinical trial for NC-2800, a delta opioid receptor agonist targeting depression. Its product portfolio includes generic and branded prescription drugs such as antithrombotics and antihypertensives, supported by manufacturing capabilities in Japan and Vietnam.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Nippon Chemiphar is a Japanese pharmaceutical company primarily engaged in the manufacture and sale of prescription (ethical) pharmaceuticals, with additional operations in healthcare, beauty, and real estate leasing. The company is also advancing its own drug discovery pipeline, including a Phase IIa clinical trial for NC-2800, a delta opioid receptor agonist targeting depression. Its product portfolio includes generic and branded prescription drugs such as antithrombotics and antihypertensives, supported by manufacturing capabilities in Japan and Vietnam.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →